D092-0184 Screening compound: N-cyclohexyl-2-(3,4-dimethoxyphenyl)-2-{N-[(furan-2-yl)methyl]-2-(1H-indol-3-yl)acetamido}acetamide

D092-0184 Screening compound: N-cyclohexyl-2-(3,4-dimethoxyphenyl)-2-{N-[(furan-2-yl)methyl]-2-(1H-indol-3-yl)acetamido}acetamide
D092-0184 Screening compound: N-cyclohexyl-2-(3,4-dimethoxyphenyl)-2-{N-[(furan-2-yl)methyl]-2-(1H-indol-3-yl)acetamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D092-0184
N-cyclohexyl-2-(3,4-dimethoxyphenyl)-2-{N-[(furan-2-yl)methyl]-2-(1H-indol-3-yl)acetamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D092-0184

Molecular Formula

C31H35N3O5 (C31 H35 N3 O5)

Compound Name

N-cyclohexyl-2-(3,4-dimethoxyphenyl)-2-{N-[(furan-2-yl)methyl]-2-(1H-indol-3-yl)acetamido}acetamide

IUPAC name

N-cyclohexyl-2-(34-dimethoxyphenyl)-2-{N-[(furan-2-yl)methyl]-2-(1H-indol-3-yl)acetamido}acetamide

SMILES

COc(ccc(C(C(NC1CCCCC1)=O)N(Cc1ccco1)C(Cc1c[nH]c2c1cccc2)=O)c1)c1OC

InChI

InChI=1S/C31H35N3O5/c1-37-27-15-14-21(17-28(27)38-2)30(31(36)33-23-9-4-3-5-10-23)34(20-24-11-8-16-39-24)29(35)18-22-19-32-26-13-7-6-12-25(22)26/h6-8,11-17,19,23,30,32H,3-5,9-10,18,20H2,1-2H3,(H,33,36)/t30-/m1/s1

InChI Key

BYNYIETUDJRRLW-SSEXGKCCSA-N

MDL Number (MFCD)

MFCD03114345

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

529.64

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.109

Distribution Coefficient, logD

5.109

Water Solubility, LogSw

-5.26

Polar Surface Area

71.654

Acid Dissociation Constant (pKa)

14.63

Base Dissociation Constant (pKb)

2.84

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

35.50

D092-0184 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

Antiviral Annotated Library (21441 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

GABA Library (7115 compounds)

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Eye
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
  • Ion Channels
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D092-0184 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D092-0184?
Check Price and Availability of D092-0184, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D092-0184 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D092-0184
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D092-0184
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D092-0184 available by request